Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Feb 6, 2021; 9(4): 943-950
Published online Feb 6, 2021. doi: 10.12998/wjcc.v9.i4.943
Table 1 Selected indicators after admission

Day 3
Day 41
Day 5
Day 6
Day 7
Day 10
Day 122
Day 14
Day 17
Day 193
Day 22
Day 244
Day 31
Reference
Liver function
ALT2739.001674.001052.00684.00264.0086.0061.0039.007-40 U/L
AST1399.00416.00155.0076.0037.0021.0023.0021.0013-35 U/L
Glutamyl transpetidase212.00178.00162.00141.00104.0078.0089.0080.0010-60 U/L
Total bile acid32.3014.8017.00 < 9.67 mol/L
Glucocholic acid29.8513.1011.60< 5.80 mol/L
Total bilirubin49.7032.7025.3017.3012.7015.3015.7012.503.4-21.1 μmol/L
Direct bilirubin43.5026.6019.2012.708.108.308.907.40< 6.8 μmol/L
Albumin42.9038.7035.9035.2036.5036.0049.1048.5040.0-55.0 g/L
Renal function
Serum creatinine344.00505.00521.00551.00589.00590.00580.00458.00242.00164.0010446-920 μmol/L
Urea15.8819.6017.3015.0010.2011.4014.8018.3015.8012.206.542.5-6.4 mmol/L
Uric acid647.00739.80550.50500.30454.80391.30406.50427.10375.1095.2-446.3 mmol/L
Uronoscopy
Urine protein2+(1)1+(0.5)
Urine chlorine187.8110-250 mmol/24 h
Urine sodium221.940-220 mmol/24 h
Urine potassium19.8525-100 mmol/24 h
Urine uric acid0.71.5-4.4 mmol/24 h
24 h urine protein303 30-150 mg/24 h
Urine-NAG22.90.3-11.5 U/L
Urine IgG149.0< 9.6 mg/L
Urine β2-microglobulin3.44< 0.2 mg/L
Urine α1-microglobulin34.0< 12.0 mg/L
Urine transferrin55.0< 2.3 mg/L
Urine amylase542.0032-641 U/L
Routine blood test
Leukocytes5.75.607.006.906.408.506.906.405.93.5-9.5 × 109/L
Neutrophils4.74.605.505.104.907.104.804.303.92.0-7.0 × 109/L
Lymphocytes0.560.600.901.000.900.901.401.401.50.8-4.0 × 109/L
Hemoglobin125116.00114.00105.0093.0092.0089.0091.0083115-150 g/L
Platelets156128.00116.00122.0098.0084.00111.00156.00161125-350 × 109/L
Inflammatory indicators
C-reactive protein1.412.906.10< 10.0 mg/L
Procalcitionin3.310.12< 0.50 ng/mL
Serum amyloid A89.607.600-10 mg/L
Erythrocyte sedimentation rate 9< 20 mm/h
Coagulation function
Prothrombin time12.4011.2011.509.5-14.1 s
Activated partial thromboplastin time25.5027.7025.1-36.5 s
Thrombin time17.2014.6011.8-17.8 s
D-dimer7.201.694.84< 0.50 mg/L
Blood gas analysis
PH7.357.35-7.45
PaCO229.435.0-48.0 mmHg
PaO281.980.0-100.0 mmHg
Actual bicarbonate radical1622-27 mmol/L
Standard bicarbonate radical1821-25 mmol/L
Electrolytes
K+4.604.404.203.803.803.503.403.803.804.004.003.5-5.3 mmol/L
Na+138.00133.00135.00137.00137.00137.00136.00137.00139.00136.00138.00137-147 mmol/L
Cl-103.00100.0099.0099.00101.0099.0095.0090.0095.0094.0098.0099-110 mmol/L
P1.501.341.641.651.301.222.041.640.83-1.48 mmol/L
Ca2+2.292.222.182.212.102.172.102.312.492.15-2.5 mmol/L
Other indicators
Serum ferritin770.711.0-306.8 ng/mL
Transferrin saturation1815%-45%
Folic acid11.43.1-20.5 ug/L
Vitamin B12453187-883 ng/L
Erythropoietin3.84.30-29.00 mIU/mL
Parathyroid hormone75.10151.4015-65 pg/mL
Serum β2-microglobulin7.321.3-2.7 mg/L
Serum amylase159.00137.00205.0030-110 U/L
Heart functionCreatine kinase and Troponin normal range
Hepatophilic virusHAV, HBV, HCV, HEV, and TORCH were negative
Immunization indicatorsANA, anti-GBM and ANCA negative; IgE 212 IU/mL (< 100 IU/mL), C3 0.57 (0.9-1.8 g/L), C4 0.1 (0.1-0.4 g/L), C1q 101 (159-233 mg/L). IgA, IgG, and IgM were normal; Widal’s test negative